Cleared Traditional

K133026 - UNBALLOON NON-OCCLUSION MODELING CATHETER

K133026 is an FDA 510(k) clearance for UNBALLOON NON-OCCLUSION MODELING CATHETER, manufactured by LeMaitre Vascular, Inc.. The device is a Class 2 Cardiovascular device with product code DQY cleared through the Traditional 510(k) pathway after a 96-day FDA review.

K133026 · LeMaitre Vascular, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2013
Decision
96d
Days
Class 2
Risk

K133026 is an FDA 510(k) clearance for the UNBALLOON NON-OCCLUSION MODELING CATHETER. Classified as Catheter, Percutaneous (product code DQY), Class II - Special Controls.

Submitted by LeMaitre Vascular, Inc. (Bedford, US). The FDA issued a Cleared decision on December 31, 2013 after a review of 96 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all LeMaitre Vascular, Inc. devices

FDA 510(k) Submission Details - K133026

510(k) Number K133026 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 26, 2013
Decision Date December 31, 2013
Days to Decision 96 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
29d faster than avg
Panel avg: 125d · This submission: 96d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQY Device Classification - Class 2, Special Controls

Product Code DQY Catheter, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQY Catheter, Percutaneous

All 785
Devices cleared under the same product code (DQY) and FDA review panel - the closest regulatory comparables to K133026.
LEADLINER CS LEAD DELIVERY SYSTEM
K133501 · Vascular Solutions, Inc. · Feb 2014
ENLIGHTN RENAL GUIDE CATHETER
K131592 · St. Jude Medical, Inc. · Jan 2014
ADVANCE CS CORONARY SINUS INFUSION CATHETER
K131204 · Cook, Inc. · Jan 2014
VIA MICROCATHETER, VIA PLUS MICROCATHETER
K132652 · Sequent Medical, Inc. · Dec 2013
SOFIA DISTAL ACCESS CATHETER
K131482 · MicroVention, Inc. · Nov 2013
TRANSGATE GUIDE CATHETER
K132542 · Stryker Neurovascular · Nov 2013